Home › Laryngeal Cancer › Idaho › Boise
Laryngeal Cancer clinical trials in Boise, ID
4 studies for Laryngeal Cancer are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Saint Alphonsus Cancer Care Center-Boise, Boise
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Boise
Laryngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Chicago, IL8 studies
- Milwaukee, WI8 studies
- Kansas City, MO7 studies
- Portland, OR7 studies
- St. Louis, MO7 studies
- Cincinnati, OH6 studies
- Richmond, VA6 studies
- Edison, NJ6 studies
- Baltimore, MD6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colon Cancer7 studies
- Colorectal Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Breast Cancer6 studies
- Melanoma6 studies
- Burkitt Lymphoma5 studies
- Pancreatic Cancer4 studies
- Myeloproliferative Neoplasms4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.